617 related articles for article (PubMed ID: 30568384)
1. Alcoholic liver disease: Utility of animal models.
Lamas-Paz A; Hao F; Nelson LJ; Vázquez MT; Canals S; Gómez Del Moral M; Martínez-Naves E; Nevzorova YA; Cubero FJ
World J Gastroenterol; 2018 Dec; 24(45):5063-5075. PubMed ID: 30568384
[TBL] [Abstract][Full Text] [Related]
2. Mouse Model of Alcoholic Steatohepatitis.
Bertola A
Methods Mol Biol; 2020; 2164():145-157. PubMed ID: 32607891
[TBL] [Abstract][Full Text] [Related]
3. Rodent Models of Alcoholic Liver Disease: Role of Binge Ethanol Administration.
Ghosh Dastidar S; Warner JB; Warner DR; McClain CJ; Kirpich IA
Biomolecules; 2018 Jan; 8(1):. PubMed ID: 29342874
[TBL] [Abstract][Full Text] [Related]
4. Metabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: Allies or enemies?
Boye A; Zou YH; Yang Y
World J Gastroenterol; 2016 Jan; 22(1):50-71. PubMed ID: 26755860
[TBL] [Abstract][Full Text] [Related]
5. Advancements in the Alcohol-Associated Liver Disease Model.
Zhu L; Li HD; Xu JJ; Li JJ; Cheng M; Meng XM; Huang C; Li J
Biomolecules; 2022 Jul; 12(8):. PubMed ID: 36008929
[TBL] [Abstract][Full Text] [Related]
6. Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease.
Wu W; Zhu B; Peng X; Zhou M; Jia D; Gu J
Biochem Biophys Res Commun; 2014 Jan; 443(1):68-73. PubMed ID: 24269813
[TBL] [Abstract][Full Text] [Related]
7. Animal Models of Alcoholic Liver Disease: Pathogenesis and Clinical Relevance.
Gao B; Xu MJ; Bertola A; Wang H; Zhou Z; Liangpunsakul S
Gene Expr; 2017 Jul; 17(3):173-186. PubMed ID: 28411363
[TBL] [Abstract][Full Text] [Related]
8. Rodent models of alcoholic liver disease: of mice and men.
Brandon-Warner E; Schrum LW; Schmidt CM; McKillop IH
Alcohol; 2012 Dec; 46(8):715-25. PubMed ID: 22960051
[TBL] [Abstract][Full Text] [Related]
9. Alcohol-associated liver disease.
Mackowiak B; Fu Y; Maccioni L; Gao B
J Clin Invest; 2024 Feb; 134(3):. PubMed ID: 38299591
[TBL] [Abstract][Full Text] [Related]
10. Rhesus monkey model of liver disease reflecting clinical disease progression and hepatic gene expression analysis.
Wang H; Tan T; Wang J; Niu Y; Yan Y; Guo X; Kang Y; Duan Y; Chang S; Liao J; Si C; Ji W; Si W
Sci Rep; 2015 Oct; 5():15019. PubMed ID: 26442469
[TBL] [Abstract][Full Text] [Related]
11. Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease.
Torres JL; Novo-Veleiro I; Manzanedo L; Alvela-Suárez L; Macías R; Laso FJ; Marcos M
World J Gastroenterol; 2018 Sep; 24(36):4104-4118. PubMed ID: 30271077
[TBL] [Abstract][Full Text] [Related]
12. Dietary supplementation in patients with alcoholic liver disease: a review on current evidence.
Ghorbani Z; Hajizadeh M; Hekmatdoost A
Hepatobiliary Pancreat Dis Int; 2016 Aug; 15(4):348-60. PubMed ID: 27498574
[TBL] [Abstract][Full Text] [Related]
13. Protocatechuic Acid-Mediated miR-219a-5p Activation Inhibits the p66shc Oxidant Pathway to Alleviate Alcoholic Liver Injury.
Fu R; Zhou J; Wang R; Sun R; Feng D; Wang Z; Zhao Y; Lv L; Tian X; Yao J
Oxid Med Cell Longev; 2019; 2019():3527809. PubMed ID: 31428222
[TBL] [Abstract][Full Text] [Related]
14. Naringenin inhibits alcoholic injury by improving lipid metabolism and reducing apoptosis in zebrafish larvae.
Lin H; Zhou Z; Zhong W; Huang P; Ma N; Zhang Y; Zhou C; Lai Y; Huang S; An H; Sun X; Gao L; Lv Z
Oncol Rep; 2017 Nov; 38(5):2877-2884. PubMed ID: 29048675
[TBL] [Abstract][Full Text] [Related]
15. Lipocalin 2 drives neutrophilic inflammation in alcoholic liver disease.
Wieser V; Tymoszuk P; Adolph TE; Grander C; Grabherr F; Enrich B; Pfister A; Lichtmanegger L; Gerner R; Drach M; Moser P; Zoller H; Weiss G; Moschen AR; Theurl I; Tilg H
J Hepatol; 2016 Apr; 64(4):872-80. PubMed ID: 26682726
[TBL] [Abstract][Full Text] [Related]
16. Development of an Animal Model for Alcoholic Liver Disease in Zebrafish.
Lin JN; Chang LL; Lai CH; Lin KJ; Lin MF; Yang CH; Lin HH; Chen YH
Zebrafish; 2015 Aug; 12(4):271-80. PubMed ID: 25923904
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte proliferation is the possible mechanism for the transient decrease in liver injury during steatosis stage of alcoholic liver disease.
Apte UM; McRee R; Ramaiah SK
Toxicol Pathol; 2004; 32(5):567-76. PubMed ID: 15603541
[TBL] [Abstract][Full Text] [Related]
18. Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease.
Trépo E; Ouziel R; Pradat P; Momozawa Y; Quertinmont E; Gervy C; Gustot T; Degré D; Vercruysse V; Deltenre P; Verset L; Gulbis B; Franchimont D; Devière J; Lemmers A; Moreno C
J Hepatol; 2013 Aug; 59(2):344-50. PubMed ID: 23557869
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis, Early Diagnosis, and Therapeutic Management of Alcoholic Liver Disease.
Kong LZ; Chandimali N; Han YH; Lee DH; Kim JS; Kim SU; Kim TD; Jeong DK; Sun HN; Lee DS; Kwon T
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31159489
[TBL] [Abstract][Full Text] [Related]
20. The Lieber-DeCarli Diet-A Flagship Model for Experimental Alcoholic Liver Disease.
Guo F; Zheng K; Benedé-Ubieto R; Cubero FJ; Nevzorova YA
Alcohol Clin Exp Res; 2018 Oct; 42(10):1828-1840. PubMed ID: 30025151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
